Advertisement

U.S. markets closed

S&P 500
4,320.06
-9.94(-0.23%)
Dow 30
33,963.84
-106.58(-0.31%)
Nasdaq
13,211.81
-12.18(-0.09%)
Russell 2000
1,776.50
-5.32(-0.30%)
Crude Oil
90.33
+0.70(+0.78%)
Gold
1,944.90
+5.30(+0.27%)

Advertisement

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Visitors trend2W10W9M

11.52

-0.24

(-2.04%)

At close: 04:00PM EDT

11.52

0.00

(0.00%)

After hours:

04:16PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Double Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	11.76
Open	11.80
Bid	10.76 x 800
Ask	12.04 x 800
Day's Range	11.44 - 12.15
52 Week Range	4.82 - 14.92
Volume	73,890
Avg. Volume	257,426

Market Cap	566.801M
Beta (5Y Monthly)	1.27
PE Ratio (TTM)	N/A
EPS (TTM)	-1.38
Earnings Date	Nov 13, 2023 - Nov 17, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	18.20

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALPN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Alpine Immune Sciences, Inc.
Daily – Vickers Top Buyers & Sellers for 02/17/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
2 years agoArgus Research

All

Zacks
5 Stocks to Buy as Drug Industry Displays Strong Fundamentals
Innovation is expected to continue driving growth in the Medical-Drugs industry. CORT, AUPH, ALPN, KALV and CRDL may prove to be good additions to one's portfolio.
Business Wire
Alpine Immune Sciences Presents First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
SEATTLE, September 12, 2023--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced that the Company presented new preclinical data from a study of povetacicept in a murine experimental autoimmune myasthenia gravis (EAMG) model during the 148th Annual American Neurological Association (ANA) Meeting in Philadelphia, PA. In addition, the Company presented safety, tol
Zacks
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?
Here is how Si-Bone (SIBN) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Advertisement

S&P 5004,320.06-9.94(-0.23%)

Dow 3033,963.84-106.58(-0.31%)

Nasdaq13,211.81-12.18(-0.09%)

Russell 20001,776.50-5.32(-0.30%)

Crude Oil90.33+0.70(+0.78%)

Gold1,944.90+5.30(+0.27%)

Alpine Immune Sciences, Inc. (ALPN)

Chart Events

Performance Outlook

Fair Value

Related Research

5 Stocks to Buy as Drug Industry Displays Strong Fundamentals

Alpine Immune Sciences Presents First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting

Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?

S&P 500
4,320.06
-9.94(-0.23%)

Dow 30
33,963.84
-106.58(-0.31%)

Nasdaq
13,211.81
-12.18(-0.09%)

Russell 2000
1,776.50
-5.32(-0.30%)

Crude Oil
90.33
+0.70(+0.78%)

Gold
1,944.90
+5.30(+0.27%)